Skip to main content
Top
Published in: Rheumatology International 8/2012

01-08-2012 | Short Communication

Polyarthritis and posterior interosseous nerve palsy associated with gastric carcinoma

Authors: Kensuke Ochi, Yukio Horiuchi, Miyoka Seki, Kazuo Nishi, Hiroyuki Nozaki, Hiroki Yabe

Published in: Rheumatology International | Issue 8/2012

Login to get access

Abstract

Cancer polyarthritis is a very rare condition. Here, we present a case of cancer polyarthritis, who also had mononeuritis simplex as a manifestation of paraneoplastic neuralgic syndrome. A 71-year-old man, who initially presented symmetrical polyarthritis and unilateral posterior interosseous nerve palsy, was subsequently diagnosed to have gastric cancer. Total gastrectomy was performed, and his polyarthritis and the palsy simultaneously disappeared within 2 weeks after the resection. His gastric cancer was found to be metastasized to his liver 16 months after the total gastrectomy; however, the polyarthritis and the palsy did not recurrent throughout his course. The polyarthritis in this case was diagnosed as a cancer polyarthritis from its features. On the other hand, the isolated posterior interosseous nerve palsy in this case met the diagnostic criteria for paraneoplastic neurological syndrome. This case was also unique in that the manifestations of paraneoplastic syndromes did not recur even after the metastasis of the primary cancer, suggesting that some specific clones in the cancer were responsive to the manifestations of paraneoplastic syndromes. Our case suggested that relapse of the manifestations of paraneoplastic syndromes may not always herald the recurrence of primary or metastatic tumour, and other tumour markers and signs should be periodically followed to search for the recurrence of the tumours.
Literature
1.
go back to reference Caldwell DS (1989) Musculoskeletal syndromes associated with malignancy. In: Kelley WN (ed) Textbook of rheumatology, 3rd edn. WB Saunders, Philadelphia, pp 1674–1689 Caldwell DS (1989) Musculoskeletal syndromes associated with malignancy. In: Kelley WN (ed) Textbook of rheumatology, 3rd edn. WB Saunders, Philadelphia, pp 1674–1689
2.
go back to reference Naschits JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D (1999) Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum 29:43–55CrossRef Naschits JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D (1999) Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum 29:43–55CrossRef
3.
go back to reference Racanelli V, Prete M, Minoia C, Favoino E, Perosa F (2008) Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 7:352–358PubMedCrossRef Racanelli V, Prete M, Minoia C, Favoino E, Perosa F (2008) Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev 7:352–358PubMedCrossRef
4.
go back to reference Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nerve system. New Eng J Med 349:1543–1554PubMedCrossRef Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nerve system. New Eng J Med 349:1543–1554PubMedCrossRef
5.
6.
go back to reference Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, For the Paraneoplastic Neurological Syndrome Euronetwork et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatr 75:1135–1140PubMedCrossRef Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, For the Paraneoplastic Neurological Syndrome Euronetwork et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatr 75:1135–1140PubMedCrossRef
7.
go back to reference Mok CC, Kwan YK (2003) Rheumatoid-like polyarthritis as a presenting feature of metastatic carcinoma: a case presentation and review of the literature. Clin Rheumatol 22:353–354PubMedCrossRef Mok CC, Kwan YK (2003) Rheumatoid-like polyarthritis as a presenting feature of metastatic carcinoma: a case presentation and review of the literature. Clin Rheumatol 22:353–354PubMedCrossRef
8.
go back to reference Stummvoll GH, Aringer M, Machold KP, Smolen JS, Raderer M (2001) Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasm. Scand J Rheumatol 30:40–44PubMedCrossRef Stummvoll GH, Aringer M, Machold KP, Smolen JS, Raderer M (2001) Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasm. Scand J Rheumatol 30:40–44PubMedCrossRef
9.
go back to reference Ochi K, Horiuchi Y, Tazaki K et al (2011) Surgical treatment of spontaneous posterior interosseous nerve palsy: a retrospective study of 50 cases. J Bone Joint Surg Br 93B:217–222 Ochi K, Horiuchi Y, Tazaki K et al (2011) Surgical treatment of spontaneous posterior interosseous nerve palsy: a retrospective study of 50 cases. J Bone Joint Surg Br 93B:217–222
10.
go back to reference Waldmann TA (1991) The interleukin-2 receptor. J Biol Chem 266:2681–2684PubMed Waldmann TA (1991) The interleukin-2 receptor. J Biol Chem 266:2681–2684PubMed
11.
go back to reference Pfinsgraff J, Buckingham RB, Killian PJ et al (1986) Palmar fasciitis and arthritis with malignant neoplasm: a paraneoplastic syndrome. Semin Arthritis Rheum 16:118–125PubMedCrossRef Pfinsgraff J, Buckingham RB, Killian PJ et al (1986) Palmar fasciitis and arthritis with malignant neoplasm: a paraneoplastic syndrome. Semin Arthritis Rheum 16:118–125PubMedCrossRef
Metadata
Title
Polyarthritis and posterior interosseous nerve palsy associated with gastric carcinoma
Authors
Kensuke Ochi
Yukio Horiuchi
Miyoka Seki
Kazuo Nishi
Hiroyuki Nozaki
Hiroki Yabe
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2047-z

Other articles of this Issue 8/2012

Rheumatology International 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.